All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| MRTX / Mirati Therapeutics, Inc.
|
|
|
|
|
|
|
|
| VTGN / Vistagen Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ACIU / AC Immune SA Call
|
|
|
|
|
|
|
|
| ATHA / LeonaBio, Inc. Call
|
|
|
|
|
|
|
|
| ROCHE GS
/ (993960LE1) |
|
|
|
|
|
|
|
| RCUS / Arcus Biosciences, Inc.
|
|
|
|
|
|
|
|
| ITOS / iTeos Therapeutics, Inc.
|
|
|
|
|
|
|
|
| VTYX / Ventyx Biosciences, Inc.
|
|
|
|
|
|
|
|
| GOSS / Gossamer Bio, Inc.
|
|
|
|
|
|
|
|
| DICE / DICE Therapeutics Inc
|
|
|
|
|
|
|
|
| EYPT / EyePoint, Inc.
|
|
|
|
|
|
|
|
| JYAC / Jiya Acquisition Corp - Class A
|
|
|
|
|
|
|
|
| APLS / Apellis Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| PYXS / Pyxis Oncology, Inc.
|
|
|
|
|
|
|
|
| KNTE / Kinnate Biopharma Inc.
|
|
|
|
|
|
|
|
| ESPR / Esperion Therapeutics, Inc.
|
|
|
|
|
|
|
|
| BMEA / Biomea Fusion, Inc.
|
|
|
|
|
|
|
|
| ALT / Altimmune, Inc.
|
|
|
|
|
|
|
|
| ZNTL / Zentalis Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| BLSA / BCLS Acquisition Corp - Class A
|
|
|
|
|
|
|
|
| BCAB / BioAtla, Inc.
|
|
|
|
|
|
|
|
| FOLD / Amicus Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ENTA / Enanta Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| CLDX / Celldex Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ACRS / Aclaris Therapeutics, Inc.
|
|
|
|
|
|
|
|
| DTIL / Precision BioSciences, Inc.
|
|
|
|
|
|
|
|
| ACAD / ACADIA Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| BLU / Bellus Health Inc
|
|
|
|
|
|
|
|
| IMGN / ImmunoGen, Inc.
|
|
|
|
|
|
|
|
| RLMD / Relmada Therapeutics, Inc.
|
|
|
|
|
|
|
|
| HSAQ / Health Sciences Acquisitions Corp 2
|
|
|
|
|
|
|
|
| OCUL / Ocular Therapeutix, Inc.
|
|
|
|
|
|
|
|
| MRUS / Merus N.V.
|
|
|
|
|
|
|
|
| SWTX / SpringWorks Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ISEE / IVERIC bio Inc
|
|
|
|
|
|
|
|
| IDYA / IDEAYA Biosciences, Inc.
|
|
|
|
|
|
|
|
| MIST / Milestone Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| UTHR / United Therapeutics Corporation
|
|
|
|
|
|
|
|
| RLMD / Relmada Therapeutics, Inc. Put
|
|
|
|
|
|
|
|
| XENE / Xenon Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| ALLK / Allakos Inc.
|
|
|
|
|
|
|
|
| RZLT / Rezolute, Inc.
|
|
|
|
|
|
|
|
| NGM / NGM Biopharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| PMVP / PMV Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| SNDX / Syndax Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| VSTM / Verastem, Inc.
|
|
|
|
|
|
|
|
| VRDN / Viridian Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ARWR / Arrowhead Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| HZNP / Horizon Therapeutics Plc
|
|
|
|
|
|
|
|
| IOVA / Iovance Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
| TERN / Terns Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| GHRS / GH Research PLC
|
|
|
|
|
|
|
|
| PCVX / Vaxcyte, Inc.
|
|
|
|
|
|
|
|
| SRPT / Sarepta Therapeutics, Inc.
|
|
|
|
|
|
|
|
| FULC / Fulcrum Therapeutics, Inc.
|
|
|
|
|
|
|
|
| TRVI / Trevi Therapeutics, Inc.
|
|
|
|
|
|
|
|
| NUVB.WS / Panacea Acquisition Corp. - Equity Warrant
|
|
|
|
|
|
|
|
| WHWK / Whitehawk Therapeutics, Inc.
|
|
|
|
|
|
|
|
| KURA / Kura Oncology, Inc.
|
|
|
|
|
|
|
|
